GO:0032454 histone H3K9 demethylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032454 (histone H3K9 demethylase activity) is a molecular function that removes methyl groups from lysine 9 of histone H3, directly reversing a repressive chromatin mark.
• This activity is carried out by JmjC-domain enzymes such as KDM3, KDM4, KDM5, and KDM7 families, which use Fe(II) and alpha-ketoglutarate as cofactors.
• H3K9 demethylases regulate gene expression, heterochromatin stability, and replication fork integrity.
• Dysregulation of H3K9 demethylases is linked to cancer, developmental delay, immune evasion, and metabolic disorders.
• CRISPR knockout, point mutation, and knock-in models are essential to dissect the causal roles of these enzymes in disease.
• EDITGENE provides custom cell models and screening services to study H3K9 demethylase function at scale.
Description
Histone H3 lysine 9 (H3K9) methylation is a hallmark of repressive chromatin, and its removal is catalyzed by histone H3K9 demethylases, classified under the Gene Ontology term GO:0032454. This enzymatic activity is critical for dynamic gene regulation, as it erases a mark that would otherwise silence genes and maintain heterochromatin. Researchers study H3K9 demethylases to understand how chromatin plasticity contributes to development, metabolism, and disease. The enzymes responsible belong to the JmjC-domain family, which are Fe(II)- and alpha-ketoglutarate-dependent dioxygenases. Their activity is essential for processes such as erythropoietin induction under hypoxia, lipogenesis, and heterochromatin disassembly at replication forks. Given their broad impact, H3K9 demethylases are attractive targets for epigenetic therapies.
histone H3K9 demethylase activity At A Glance
| GO ID | GO:0032454 |
|---|---|
| GO term | histone H3K9 demethylase activity |
| Ontology | molecular_function |
| Synonym | histone demethylase activity (H3-K9 specific); histone H3-K49 demethylase activity; histone H3-methyl-lysine-9 demethylase activity |
| Major function | Removal of methyl groups from histone H3 lysine 9, reversing repressive chromatin marks |
| Cofactors | Fe(II) and alpha-ketoglutarate (for JmjC-domain enzymes) |
| Substrate | Methylated histone H3 lysine 9 (mono-, di-, or tri-methylated) |
| Major enzyme families | KDM3/JMJD1, KDM4/JMJD2, KDM5/JARID1, KDM7 |
What Is GO:0032454?
GO:0032454, histone H3K9 demethylase activity, is defined as the catalysis of the removal of a methyl group from a modified lysine residue at position 9 of the histone H3 protein. This activity reverses mono-, di-, or tri-methylation of H3K9, thereby altering chromatin structure and gene expression. It is a molecular function that contributes to the broader regulation of histone methylation dynamics.
Why Is histone H3K9 demethylase activity Important in Cell Biology?
Histone H3K9 demethylase activity is central to epigenetic regulation because it erases a repressive mark, enabling gene activation and chromatin remodeling. Its dysregulation is implicated in cancer, where it can promote immune evasion or metabolic reprogramming, and in neurodevelopmental disorders such as KDM4B-associated global developmental delay. Understanding this activity is therefore crucial for developing epigenetic therapies.
• Reverses H3K9 methylation, a key repressive chromatin mark, to activate gene expression.
• Regulates heterochromatin assembly and disassembly at replication forks, ensuring genome stability.
• Modulates hypoxia-induced erythropoietin expression via JMJD1A.
• Influences lipid metabolism through JMJD2B in LXRalpha-dependent lipogenesis.
• Promotes immune evasion in cancer by recruiting SETDB1 to silence retroelements.
• Mutations in KDM4B cause global developmental delay and neuroanatomical defects.
• Plays a role in sex determination, as maternal iron deficiency affects H3K9 demethylation.
• Hairless (HR) protein functions as an H3K9 demethylase, linking it to hair and skin biology.
• Serves as a target for epigenetic therapies in cancer and other diseases.
What Happens During histone H3K9 demethylase activity?
Substrate recognition and binding
In simple terms: The enzyme finds and binds to the methylated histone H3K9 mark.
H3K9 demethylases recognize methylated lysine 9 on histone H3 through specialized domains, such as PHD and Tudor domains, which read the methylation state. This binding positions the catalytic domain for subsequent demethylation.
Catalytic demethylation
In simple terms: The enzyme removes the methyl group using iron and alpha-ketoglutarate.
JmjC-domain demethylases catalyze the oxidative removal of methyl groups from H3K9me1/2/3 in a reaction that requires Fe(II) and alpha-ketoglutarate as cofactors. This reaction generates formaldehyde and succinate as byproducts.
Chromatin remodeling and gene activation
In simple terms: Removing the methyl mark opens up chromatin so genes can be turned on.
Demethylation of H3K9 leads to a less repressive chromatin state, facilitating transcriptional activation. For example, JMJD1A co-activates erythropoietin expression under hypoxia by demethylating H3K9.
Heterochromatin dynamics at replication forks
In simple terms: The enzyme helps rebuild heterochromatin after DNA replication.
During DNA replication, H3K9 demethylases contribute to the disassembly and reassembly of heterochromatin to maintain fork stability. This dynamic regulation ensures proper chromatin inheritance.
Key Genes Involved in GO:0032454 histone H3K9 demethylase activity
The following genes encode enzymes or associated factors that exhibit histone H3K9 demethylase activity or regulate it.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KDM3A (JMJD1A) | H3K9 demethylase; co-activates erythropoietin under hypoxia | Hypoxia response, metabolism, cancer |
| KDM4B (JMJD2B) | H3K9 demethylase; regulates lipogenesis | Metabolic disorders, developmental delay |
| KDM4A (JMJD2A) | H3K9 demethylase; involved in heterochromatin regulation | Cancer, replication stress |
| KDM4C (JMJD2C) | H3K9 demethylase; promotes gene activation | Cancer, stem cell biology |
| KDM5B (JARID1B) | H3K9 demethylase; recruits SETDB1 to silence retroelements | Immune evasion, cancer |
| KDM7A (KIAA1718) | H3K9 demethylase; involved in neuronal differentiation | Neurodevelopment |
| HR (Hairless) | H3K9 demethylase; regulates hair cycle | Skin biology, hair disorders |
| KDM3B | H3K9 demethylase; implicated in transcription | Cancer, development |
| KDM4D | H3K9 demethylase; involved in spermatogenesis | Reproductive biology |
| KDM5A | H3K9 demethylase; regulates cell proliferation | Cancer, differentiation |
| KDM5C | H3K9 demethylase; X-linked intellectual disability | Neurodevelopment |
| KDM7B (PHF8) | H3K9 demethylase; linked to cleft lip/palate | Craniofacial development |
| KDM4E | H3K9 demethylase; testis-specific | Reproductive biology |
| KDM3C (JMJD1C) | H3K9 demethylase; regulates metabolism | Metabolic disorders |
| SETDB1 | H3K9 methyltransferase; antagonizes demethylases | Immune evasion, cancer |
| LXRalpha | Nuclear receptor; regulates JMJD2B expression | Lipogenesis |
| EPO | Erythropoietin; target of JMJD1A co-activation | Hypoxia response |
| HIF1A | Hypoxia-inducible factor; cooperates with JMJD1A | Hypoxia signaling |
How Is histone H3K9 demethylase activity Regulated?
Histone H3K9 demethylase activity is regulated at multiple levels. Expression of KDM4B is induced by LXRalpha in lipogenesis, while JMJD1A cooperates with HIF1A under hypoxia to activate erythropoietin. Additionally, KDM5B recruits SETDB1 to silence retroelements, showing interplay with methylation machinery. The activity is also dynamically regulated during the cell cycle to ensure heterochromatin stability at replication forks.
histone H3K9 demethylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KDM4B | Global developmental delay, neuroanatomical defects | Knockout mouse, patient-derived iPSCs |
| KDM5B | Cancer immune evasion | Knockout melanoma models, syngeneic mouse |
| KDM3A | Hypoxia-related disorders, cancer | Knockout cell lines, xenografts |
| KDM4B | Metabolic disorders, lipogenesis | Liver-specific knockout mice |
| HR | Hair disorders | Skin-specific knockout mice |
Cancer
H3K9 demethylases are frequently overexpressed in cancers, where they promote oncogenesis by activating growth-promoting genes and silencing tumor suppressors. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements, thereby preventing immune recognition of tumor cells. Targeting these enzymes with small-molecule inhibitors is an active area of epigenetic therapy.
Neurodevelopmental disorders
Heterozygous variants in KDM4B cause global developmental delay and neuroanatomical defects, highlighting the critical role of H3K9 demethylation in brain development. Other KDM family members, such as KDM5C, are linked to X-linked intellectual disability.
Metabolic disorders
JMJD2B (KDM4B) plays a role in LXRalpha-dependent lipogenesis, linking H3K9 demethylation to lipid metabolism and potential metabolic disorders such as obesity and fatty liver. JMJD1A also regulates metabolic gene expression under hypoxia.
Reproductive and developmental defects
Maternal iron deficiency impairs H3K9 demethylation, leading to male-to-female sex reversal in mouse embryos, demonstrating the importance of this activity in sex determination. Hairless (HR) mutations affect hair cycling, and its H3K9 demethylase activity is relevant to hair disorders.
From histone H3K9 demethylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of KDM4B affect neurodevelopment? | KDM4B knockout mouse or human iPSC-derived neurons |
| Does KDM5B promote immune evasion? | KDM5B knockout cancer cell lines in immunocompetent mice |
| How does JMJD1A regulate erythropoietin? | JMJD1A knockout cells under hypoxia |
| What is the role of H3K9 demethylation in sex determination? | Maternal iron deficiency mouse model |
| Does KDM4B regulate lipogenesis? | Liver-specific KDM4B knockout mice |
| How does Hairless demethylase affect hair cycle? | Hairless knockout mice |
How to Study the histone H3K9 demethylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide localization of H3K9 methylation or demethylases | Mapping chromatin changes |
| RNA-seq | Transcriptional changes | Gene expression profiling upon KO/overexpression |
| Mass spectrometry | Histone modification levels and interactome | Global epigenetic profiling |
| Western blot | Specific histone methylation marks | Validation of demethylase activity |
| Immunofluorescence | Nuclear localization and heterochromatin foci | Cellular imaging |
| In vitro demethylase assay | Enzymatic activity | Drug screening |
| CRISPR screen | Functional importance of demethylases | Cancer dependency mapping |
| ATAC-seq | Chromatin accessibility | Assessing open chromatin after demethylation |
Chromatin immunoprecipitation (ChIP)
ChIP with antibodies against H3K9me2/3 or the demethylase itself can map binding sites and changes in methylation status upon enzyme manipulation.
Mass spectrometry-based proteomics
Quantitative proteomics can identify interacting partners and global changes in histone modifications following knockout or overexpression of H3K9 demethylases.
RNA sequencing (RNA-seq)
RNA-seq reveals transcriptional changes caused by loss or gain of H3K9 demethylase activity, identifying target genes and pathways.
Enzymatic activity assays
In vitro demethylase assays using recombinant enzymes and methylated histone peptides measure catalytic activity and screen for inhibitors.
How CRISPR Can Be Used to Study GO:0032454 histone H3K9 demethylase activity
Knockout
CRISPR knockout of H3K9 demethylase genes (e.g., KDM4B, KDM5B) in cell lines or primary cells can reveal loss-of-function phenotypes, such as altered proliferation, differentiation, or immune response. Knockout models are essential to establish causality in disease pathways.
Point Mutation
Introducing point mutations in the catalytic domain (e.g., JmjC domain) of H3K9 demethylases can abolish enzymatic activity while preserving protein interactions, allowing separation of catalytic and non-catalytic functions. Such models are valuable for dissecting precise molecular mechanisms.
Knock-in
Knock-in of tagged (e.g., FLAG, HA) or fluorescently labeled demethylases enables endogenous expression, localization, and interactome studies under physiological conditions. Knock-in of disease-associated mutations (e.g., KDM4B variants) can model human disorders.
Overexpression
Overexpression of wild-type or mutant H3K9 demethylases via lentiviral or CRISPR activation can mimic gain-of-function states observed in cancers. This approach helps identify downstream targets and oncogenic cooperation.
How EDITGENE Supports histone H3K9 demethylase activity Research
Researchers studying histone H3K9 demethylase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of H3K9 demethylases and their regulators.
Contact EDITGENE today to design your custom CRISPR model for histone H3K9 demethylase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| KDM4D Knockout HEK293 Cell Line | EDJ-KQ1044 | Human | 55693 | Details Get a Quote |
| KDM3A Knockout HEK293 Cell Line | EDJ-KQ2029 | Human | 55818 | Details Get a Quote |
| PHF2 Knockout HEK293 Cell Line | EDJ-KQ2175 | Human | 5253 | Details Get a Quote |
| KDM4C Knockout HEK293 Cell Line | EDJ-KQ2354 | Human | 23081 | Details Get a Quote |
| KDM4A Knockout HEK293 Cell Line | EDJ-KQ3098 | Human | 9682 | Details Get a Quote |
| HR Knockout HEK293 Cell Line | EDJ-KQ4142 | Human | 55806 | Details Get a Quote |
| KDM4B Knockout HEK293 Cell Line | EDJ-KQ7780 | Human | 23030 | Details Get a Quote |
| PHF8 Knockout HEK293 Cell Line | EDJ-KQ7848 | Human | 23133 | Details Get a Quote |
| JMJD1C Knockout HEK293 Cell Line | EDJ-KQ8035 | Human | 221037 | Details Get a Quote |
| KDM7A Knockout HEK293 Cell Line | EDJ-KQ8844 | Human | 80853 | Details Get a Quote |
| KDM3B Knockout HEK293 Cell Line | EDJ-KQ11221 | Human | 51780 | Details Get a Quote |
| KDM1A Knockout HEK293 Cell Line | EDJ-KQ13915 | Human | 23028 | Details Get a Quote |
| KDM4E Knockout HEK293 Cell Line | EDJ-KQ13917 | Human | 390245 | Details Get a Quote |
| KDM4F Knockout HEK293 Cell Line | EDJ-KQ13918 | Human | 100129053 | Details Get a Quote |
| KDM1A Knockout A-549 Cell Line | EDJ-KQ18105 | Human | 23028 | Details Get a Quote |
Displaying Records 1 To 15 Of 57 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About histone H3K9 demethylase activity
What is histone H3K9 demethylase activity?
It is the enzymatic removal of methyl groups from lysine 9 of histone H3, reversing a repressive chromatin mark, as defined by GO:0032454.
What genes are involved in histone H3K9 demethylase activity?
Key genes include KDM3A, KDM4B, KDM5B, KDM7A, and HR, among others.
What diseases are associated with H3K9 demethylases?
They are linked to cancer, neurodevelopmental disorders, metabolic diseases, and reproductive defects.
How is H3K9 demethylase activity regulated?
It is regulated by cofactors (Fe(II), alpha-ketoglutarate), interacting proteins, and signaling pathways such as hypoxia and LXRalpha.
What are the cofactors for H3K9 demethylases?
JmjC-domain demethylases require Fe(II) and alpha-ketoglutarate as cofactors.
Can CRISPR be used to study H3K9 demethylases?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect their functions.
What is the role of KDM4B in development?
Heterozygous variants in KDM4B cause global developmental delay and neuroanatomical defects.
How does JMJD1A regulate erythropoietin?
JMJD1A acts as a co-activator of erythropoietin expression under hypoxia by demethylating H3K9.
What is the link between H3K9 demethylases and cancer immunity?
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.
What methods are used to measure H3K9 demethylase activity?
ChIP-seq, RNA-seq, mass spectrometry, and in vitro enzymatic assays are commonly used.
Conclusion
Histone H3K9 demethylase activity (GO:0032454) is a fundamental epigenetic function that reverses repressive chromatin marks and controls gene expression, development, and disease. Its dysregulation contributes to cancer, neurodevelopmental disorders, and metabolic diseases, making it a prime target for therapeutic intervention. CRISPR-based models and advanced screening technologies are essential to unravel its complex biology and translate findings into clinical applications.
References
- 1. Gold S et al.. 2024. Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges.. J Clin Invest 134(20) PMID: 39403928
- 2. Kim JH et al.. 2020. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.. Int J Mol Sci 21(21) PMID: 33167594
- 3. Okashita N et al.. 2025. Maternal iron deficiency causes male-to-female sex reversal in mouse embryos.. Nature 643(8070):262-270 PMID: 40468068
- 4. Zhang SM et al.. 2021. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.. Nature 598(7882):682-687 PMID: 34671158
- 5. Duncan AR et al.. 2020. Heterozygous Variants in KDM4B Lead to Global Developmental Delay and Neuroanatomical Defects.. Am J Hum Genet 107(6):1170-1177 PMID: 33232677
- 6. Tian Z et al.. 2019. Histone H3K9 demethylase JMJD1A is a co-activator of erythropoietin expression under hypoxia.. Int J Biochem Cell Biol 109:33-39 PMID: 30716474
- 7. Liu L et al.. 2014. Hairless is a histone H3K9 demethylase.. FASEB J 28(4):1534-42 PMID: 24334705
- 8. Gaggioli V et al.. 2023. Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability.. Nat Cell Biol 25(7):1017-1032 PMID: 37414849
